Page 137 - Influenza Report

Referenze 137

27. Hien TT, Nguyen TL, Nguyen TD, et al. Avian influenza A (H5N1) in 10 patients in
Vietnam. N Engl J Med 2004; 350: 1179-88. Full text at
http://content.nejm.org/cgi/content/abstract/350/12/1179
28. Ho MS, Su IJ. Preparing to prevent severe acute respiratory syndrome and other
respiratory infections. Lancet Infect Dis 2004; 4: 684-9. Abstract:
http://amedeo.com/lit.php?id=15522680

29. Hoffmann C, Kamps BS. Drugs. In: Influenza Report 2006; Wuppertal 2006. Available
from http://InfluenzaReport.com/ir/drugs.htm
30. Hoffmann C, Korsman S, Kamps BS. Treatment and Prophylaxis. In: Influenza Report
2006; Wuppertal 2006. Available from http://InfluenzaReport.com/ir/tp.htm
31. IHR 2005. International Health Regulations 2005. Available at:
http://www.who.int/gb/ebwha/pdf_files/WHA58/WHA58_3-en.pdf

32. Imuta F, Toyoda M, Toyoda T. New application method of zanamivir with a straw.
Pediatr Int 2003; 45: 366-7.
33. Johnson NP, Mueller J. Updating the accounts: Global mortality of the 1918-20
"Spanish" influenza pandemic. Bull Hist Med 2002; 76: 105-15. Abstract:
http://amedeo.com/lit.php?id=11875246

34. Kiso M, Mitamura K, Sakai-Tagawa Y, et al. Resistant influenza A viruses in children
treated with oseltamivir: descriptive study. Lancet 2004; 364: 759-65. Abstract:
http://amedeo.com/lit.php?id=15337401
35. Korsman S. Vaccines. In: Influenza Report 2006; Wuppertal 2006. Available from
http://InfluenzaReport.com/ir/vaccines.htm
36. Lipatov AS, Govorkova EA, Webby RJ, et al. Influenza: emergence and control. J Virol
2004; 78: 8951-9. Full text at
http://jvi.asm.org/cgi/content/full/78/17/8951?view=long&pmid=15308692

37. Longini IM Jr, Halloran ME, Nizam A, Yang Y. Containing pandemic influenza with
antiviral agents. Am J Epidemiol 2004; 159: 623-33. Abstract:
http://amedeo.com/lit.php?id=15033640
38. Longini IM Jr, Nizam A, Xu S, Ungchusak K, Hanshaoworakul W, Cummings DA,
Halloran ME. Containing pandemic influenza at the source. Science. 2005 Aug
12;309(5737):1083-7.
39. McKimm-Breschkin J, Trivedi T, Hampson A, et al. Neuraminidase sequence analysis
and susceptibilities of influenza virus clinical isolates to zanamivir and oseltamivir.
Antimicrob Agents Chemother 2003; 47: 2264-72. Full text at
http://aac.asm.org/cgi/content/full/47/7/2264?view=long&pmid=12821478
40. Moscona A. Oseltamivir resistance--disabling our influenza defenses. N Engl J Med
2005; 353: 2633-6. http://amedeo.com/lit.php?id=16371626 - Full text at
http://content.nejm.org/cgi/content/full/353/25/2633

41. Osterholm MT. Preparing for the next pandemic. N Engl J Med 2005; 352: 1839-42.
Full text at http://content.nejm.org/cgi/content/full/352/18/1839
42. PPHSN 2004. Pacific Public Health Surveillance Network Guidelines for Influenza
Preparedness & Control and Influenza Pandemic Preparedness (Part II). Prepared in
Consultation with the PPHSN Influenza Specialist Group (ISG). Available at:
http://www.spc.org.nc/phs/pphsn/Publications/Guidelines/Influenza/PPHSN_Influenza_
pa ndemic-guidelines-partII-final_draft-oct04.pdf